Press releases

Warsaw, 9 June 2016

Ezetrol

BIOTON S.A. and MSD, a part of the American concern Merck & Co., have concluded an agreement according to which BIOTON shall cooperate with MSD within the scope of development of the market of hypercholesterolemia treatment with an innovative medication - Ezetrol (ezetymib).

czytaj więcej

Warsaw, 26 May 2016

CHANGES IN CORPORATE BODIES OF BIOTON

On 25 May 2016 the Supervisory Board of Bioton S.A. ("Bioton", "Company") decided to form a strategy development committee whose principal task will be to raise Bioton's operations to global level and to develop diabetes products portfolio, as the main area of Company operation. Therefore, the Supervisory Board has decided to delegate its Chairman, Mr Jubo Liu and a Vice Chairman, Mr Dariusz Trzeciak, to directly supervise the process of development and implementation of the new strategy of the Company.

czytaj więcej

Current reports

Warsaw, 13 June 2016

Current report 2016/29 dated 10.06.2016

Confidential information (execution of the conditional agreement on disposal of INDAR ZAO shares)

czytaj więcej

Warsaw, 7 June 2016

Current report 2016/28 dated 06.06.2016

Announcement of a candidacy for a member of the Supervisory Board of BIOTON S.A.

czytaj więcej